心血管疾病在老年人和非常老年人的流行病学和管理
Giuseppe Galati1,2, Olga Germanova2, Gianmarco Dacquino1
1Cardiovascular Department, I.R.C.C.S. MultiMedica, Milan, Italy.
European journal of preventive cardiology
|September 22, 2025
概括
心血管疾病 (CVD) 对老年人的影响不同. 心力衰竭 (HF) 是一个主要问题,需要脆弱性评估来指导管理和预防有害干预.
科学领域:
- 老年学是一门学科.
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 心血管疾病 (CVD) 在全球人口老龄化中构成了重大健康挑战.
- 与年轻的人群相比,老年人和非常老年人表现出不同的心血管疾病流行病学和影响.
研究的目的:
- 审查老年人心血管疾病的流行病学和新型管理策略.
- 强调特定的心血管疾病,如心力衰竭 (HF),缺血性心脏病,心房动 (AF),中风,膜心脏病和心肌病 (CMP).
- 根据功能能力和各种衰老概念 (血管,生物,预期年龄) 定义"老年人",并探索脆弱性在心血管疾病管理中的作用.
主要方法:
- 这是一个叙事综述,综合了当前关于老年人心血管疾病的文献.
- 关键目标包括定义老龄化人口和评估脆弱性对治疗决策的影响.
主要成果:
- 心力衰竭 (HF) 被确定为对老年人的生活质量和数量影响最大的心血管疾病.
- 心血管疾病带来了独特的挑战,需要针对老年人进行量身定制的治疗.
- 脆弱性评估对于优化干预措施的益处和避免干预措施的危害至关重要.
结论:
- 老年人是一个不断增长的人口,具有独特的心血管疾病概况.
- 管理策略必须考虑到个体患者的特征,包括脆弱性.
- 多学科的脆弱性评估对于指导决策至关重要,特别是避免徒劳的侵略性治疗.
相关概念视频
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Rheumatic Heart Disease III: Medical Management
289
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232

